相关实验视频
Updated: Jul 1, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
Published on: June 21, 2018
一个基于GraphSAGE的模型,只使用指纹来预测药物相互作用
Bo Zhou1,2, Bing Ran3, Lei Chen3
1Institute of Wound Prevention and Treatment, Shanghai University of Medicine and Health Sciences, Shanghai 201318, China.
这项研究引入了一种新的深度学习模型,用于使用指纹特征和图形卷积网络预测药物相互作用 (DDI). 该模型实现了高精度,为改善组合药物治疗提供了洞察力,并避免了不良事件.
科学领域:
- 药理学 药理学 是一个学科.
- 计算生物学 计算生物学
- 人工智能的人工智能
背景情况:
- 组合药物治疗提高了复杂疾病的疗效,但有副作用的风险.
- 准确预测药物相互作用 (DDI) 对于安全有效的治疗至关重要.
- 现有的用于DDI预测的深度学习模型通常需要大量的药物属性数据,这限制了它们的适用性.
研究的目的:
- 开发一种基于深度学习的新型模型来预测DDI.
- 设计一个模型,利用常见的药物指纹特征,以实现更广泛的应用.
- 与现有方法相比,提高DDI预测的准确性和可靠性.
主要方法:
- 使用常见的指纹特征来表示药物.
- 使用图形卷积网络方法GraphSAGE,将指纹特征与药物相互作用网络融合,生成高级药物特征.
- 内产物被用来得分潜在药物对的强度.
主要成果:
- 该模型通过十倍交叉验证实现了高性能,AUROC为0.9704,AUPR为0.9727.
- 性能超过了仅使用指纹特征的模型,并且与使用更全面药物特性的模型竞争.
- 废弃试验证实了模型组件的意义,分析揭示了具有不同网络度的药物的优点和局限性.
结论:
- 开发的模型有效地使用可访问的药物指纹特征和图形卷积网络预测DDI.
- 确定的新型DDI表明潜在的治疗益处 (例如,PEA和大麻素) 和风险 (例如,WIN 55,212-2和大麻素).
- 这种方法为优化组合疗法和减轻不良药物事件提供了宝贵的见解.
更多相关视频
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
07:40A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
Published on: May 27, 2021
相关概念视频
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Agonism and Antagonism: Quantification
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion,...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Physiological Pharmacokinetic Models: Assumption with Protein Binding